ARTICLE SUMMARY:
We remember our friend and colleague David Cassak. Orthopedics M&A has been unexpectedly robust this year as some investors turn to those mature markets as a hedge against tech investments. Singapore’s MedTech Catapult launches to help innovators turn promising innovations into market-ready products and ventures. A long-awaited FDA labeling change expands EVAR treatment to ruptured AAAs. Expanding value-based care in MSK. Plus profiles of Cyted, Gravitas, Plio, Minovia and VahatiCor.
